
Intravenous IgG Reduces Pathogenic Autoantibodies, Serum IL-6 Levels, and Disease Severity in Experimental Bullous Pemphigoid Models
Keywords: BP; bullous pemphigoid; BP-IgG; IgG from patients with bullous pemphigoid; COL17; type XVII collagen; DEJ; dermalâepidermal junction; IVIG; intravenous administration of high-dose IgG; NC16A; noncollagenous 16A domain; SG-IgG; IgG from skin-grafted mice